Anda belum login :: 26 Jul 2025 07:58 WIB
Detail
ArtikelImplantable Cardioverter–Defibrillators after Myocardial Infarction  
Oleh: Myerburg, Robert J.
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 359 no. 21 (Nov. 2008), page 2245.
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: N08.K.2008.06
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelPersons who survive a myocardial infarction are at increased risk for sudden death from cardiac causes, owing largely to ventricular tachyarrhythmias.1,2 The risk of sudden death after a myocardial infarction is highest during the first 12 months and then declines.3,4,5,6 Although survival during the acute and early convalescent phases after a myocardial infarction has improved as a result of therapies introduced during the past 25 years,7 a delayed increase in the risk of sudden death from cardiac causes after the initial convalescent phase has become evident. Those in whom ventricular remodeling and heart failure develop are at greatest risk8,9 . . .
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)